| pubmed-article:8420311 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8420311 | lifeskim:mentions | umls-concept:C0025320 | lld:lifeskim |
| pubmed-article:8420311 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:8420311 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:8420311 | lifeskim:mentions | umls-concept:C0014912 | lld:lifeskim |
| pubmed-article:8420311 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8420311 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:8420311 | lifeskim:mentions | umls-concept:C0694643 | lld:lifeskim |
| pubmed-article:8420311 | lifeskim:mentions | umls-concept:C1456501 | lld:lifeskim |
| pubmed-article:8420311 | pubmed:issue | 1 Pt 1 | lld:pubmed |
| pubmed-article:8420311 | pubmed:dateCreated | 1993-2-11 | lld:pubmed |
| pubmed-article:8420311 | pubmed:abstractText | The purpose of our study was to evaluate the effects of three dosages of transdermally administered 17 beta-estradiol on markers of bone loss in women who had recently undergone surgical menopause. | lld:pubmed |
| pubmed-article:8420311 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8420311 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8420311 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8420311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8420311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8420311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8420311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8420311 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8420311 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8420311 | pubmed:issn | 0002-9378 | lld:pubmed |
| pubmed-article:8420311 | pubmed:author | pubmed-author:WahnerH WHW | lld:pubmed |
| pubmed-article:8420311 | pubmed:author | pubmed-author:JuddH LHL | lld:pubmed |
| pubmed-article:8420311 | pubmed:author | pubmed-author:RiggsB LBL | lld:pubmed |
| pubmed-article:8420311 | pubmed:author | pubmed-author:FieldC SCS | lld:pubmed |
| pubmed-article:8420311 | pubmed:author | pubmed-author:OryS JSJ | lld:pubmed |
| pubmed-article:8420311 | pubmed:author | pubmed-author:HerrmannR RRR | lld:pubmed |
| pubmed-article:8420311 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8420311 | pubmed:volume | 168 | lld:pubmed |
| pubmed-article:8420311 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8420311 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8420311 | pubmed:pagination | 114-21 | lld:pubmed |
| pubmed-article:8420311 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:meshHeading | pubmed-meshheading:8420311-... | lld:pubmed |
| pubmed-article:8420311 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8420311 | pubmed:articleTitle | Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial. | lld:pubmed |
| pubmed-article:8420311 | pubmed:affiliation | Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905. | lld:pubmed |
| pubmed-article:8420311 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8420311 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8420311 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8420311 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8420311 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8420311 | lld:pubmed |
